4.6 Article

Measurement of Cetuximab and Panitumumab-Unbound Serum EGFR Extracellular Domain Using an Assay Based on Slow Off-Rate Modified Aptamer (SOMAmer) Reagents

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Molecular Mechanisms of Resistance to Cetuximab and Panitumumab in Colorectal Cancer

Alberto Bardelli et al.

JOURNAL OF CLINICAL ONCOLOGY (2010)

Article Chemistry, Multidisciplinary

Expanding the Chemistry of DNA for in Vitro Selection

Jonathan D. Vaught et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)

Article Biotechnology & Applied Microbiology

Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins

Darius Ghaderi et al.

NATURE BIOTECHNOLOGY (2010)

Article Multidisciplinary Sciences

Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery

Larry Gold et al.

PLOS ONE (2010)

Article Cell Biology

ErbB receptors and signaling pathways in cancer

Nancy E. Hynes et al.

CURRENT OPINION IN CELL BIOLOGY (2009)

Article Medicine, General & Internal

Cetuximab-induced anaphylaxis and IgE specific for galactose-α-1,3-galactose

Christine H. Chung et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Biochemistry & Molecular Biology

Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members

D. L. Wheeler et al.

ONCOGENE (2008)

Review Pathology

Circulating oncoproteins HER2/neu, EGFR and CAIX (MN) as novel cancer biomarkers

Walter P. Carney

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2007)

Article Medicine, General & Internal

Pegaptanib for neovascular age-related macular degeneration

ES Gragoudas et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)